IL18 and mastocytosis: We found that C57BL/6 mice pretreated with IL-18 and IL-2 developed mucosal mastocytosis with high levels of serum mMCP1, an activation marker of MMC, and became able to promptly expel the intestinal nematode Strongyloides venezuelensis.